Roquefort Therapeutics (ROQAF, $0.02) was a top loser over the last three months, falling to $0.02 per share. A.I.dvisor analyzed 817 stocks in the Biotechnology Industry for the 3-month period ending July 14, 2025, and found that of them (6) exhibited an Uptrend while of them (3) demonstrated a Downtrend.